Patent · US Active

Method of detecting a subfraction of proBNP

US7807380B2 · kind B2 · utility

2Cited by

2References

4Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Anneliese Borgya · Manheim, DE
Andreas Gallusser · Penzberg, DE
Michael Grol · Feldafing, DE
Klaus Hallermayer · Feldafing, DE
Volker Klemt · Waldshut-Tiengen, DE
Christoph Seidel · Weilheim, DE

Key dates

Filing date	Dec 5, 2006
Grant date	Oct 5, 2010
Priority date	—
Expiry date	Dec 5, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S436/811
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.